Scott D. Berkowitz

28.5k citations

195 papers · 17.0k indexed · 5 hit papers · h-index 54

Impact in

Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 0.05%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac electrophysiology and arrhythmias

Papers in

Internal Medicine 99
- Venous Thromboembolism Diagnosis and Management 99
Cardiology and Cardiovascular Medicine 146
- Atrial Fibrillation Management and Outcomes 100
- Antiplatelet Therapy and Cardiovascular Diseases 55
- Acute Myocardial Infarction Research 38
- Cardiac Arrhythmias and Treatments 28

Co-authors: Keith A.A. Fox Manesh R. Patel Kenneth W. Mahaffey Daniel E. Singer Christopher C. Nessel Graeme J. Hankey Jonathan P. Piccini Günter Breithardt
Journals: Journal of the American College of Cardiology (25 papers)American Heart Journal (16 papers)Circulation (15 papers)Blood (15 papers)European Heart Journal (8 papers)
Partner nations: United States Germany Canada

In The Last Decade

Scott D. Berkowitz

188 papers receiving 16.4k citations

Hit Papers

5 papers align trajectories log scale

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism 2017 · 492 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 New England Journal of Medicine
2013 Thrombosis Journal
2011 New England Journal of Medicine
2009 The Lancet
2001 Circulation

Peers

Countries citing papers authored by Scott D. Berkowitz

Since Specialization

Citations

This map shows the geographic impact of Scott D. Berkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Berkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Berkowitz more than expected).

Fields of papers citing papers by Scott D. Berkowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Berkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Berkowitz. The network helps show where Scott D. Berkowitz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Scott D. Berkowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott D. Berkowitz Line = papers co-authored together Scott D. Berkowitz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD Journal of the American Heart Association ·Nengceu Siti Rohimah, Michael Szarek, E. Sebastian Debus, Mark R. Nehler, Sonia S. Anand, Manesh R. Patel, Ákos F. Pap, Hsiaowei Deng, О.А. Шагаєва, Lloyd Haskell, Eva Muehlhofer, Scott D. Berkowitz, Rupert Bauersachs, Marc P. Bonaca	2025	0
2	Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence Clinical Therapeutics ·Mario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, Connie N. Hess, 雄基田口, Federica Ilardi, Giuseppe Giugliano, Anna Franzone, Giuseppe Gargiulo, Scott D. Berkowitz, Håkon Ihle-Hansen, Giovanni Esposito, Marc P. Bonaca	2025	3
3	Quantitative Benefit–Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial Journal of the American Heart Association ·Žhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert Bauersachs, Scott D. Berkowitz, Lloyd Haskell, Elliot S. Barnathan, Marc P. Bonaca	2024	3
4	Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis Journal of the American Heart Association ·Josephine Harrington, Anne S. Hellkamp, Kenneth W. Mahaffey, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A.A. Fox, Daniel E. Singer, Shaun G. Goodman, Manesh R. Patel, Jonathan P. Piccini	2024	1
5	Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization Journal of the American College of Cardiology ·Mario Enrico Canonico, Cecilia C. Low Wang, Judith Hsia, А.Н. Пушин, Mark R. Nehler, Manesh R. Patel, Sonia S. Anand, J. Ycas, Warren H. Capell, Eva Muehlhofer, Lloyd Haskell, Scott D. Berkowitz, Rupert Bauersachs, Marc P. Bonaca	2024	2
6	Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD Circulation ·Nengceu Siti Rohimah, E. Sebastian Debus, Mark R. Nehler, Manesh R. Patel, Sonia S. Anand, Eva Muehlhofer, Lloyd Haskell, Scott D. Berkowitz, Rupert Bauersachs, Marc P. Bonaca	2024	2
7	Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD Circulation ·Jennifer A. Rymer, Sonia S. Anand, E. Sebastian Debus, Lloyd Haskell, Connie N. Hess, W. Schuyler Jones, Eva Muehlhofer, Scott D. Berkowitz, Rupert Bauersachs, Marc P. Bonaca, Manesh R. Patel	2023	5
8	Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone Journal of Thrombosis and Haemostasis ·Scott D. Berkowitz, Rupert Bauersachs, Michael Szarek, Mark R. Nehler, E. Sebastian Debus, Manesh R. Patel, Sonia S. Anand, Warren H. Capell, Connie N. Hess, Judith Hsia, Nicholas J. Leeper, David Brasil, Lajos Mátyás, Rafael Díaz, Marianne Brodmann, Eva Muehlhofer, Lloyd Haskell, Marc P. Bonaca	2022	7
9	Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD Journal of the American Heart Association ·Connie N. Hess, Iris Baumgärtner, Sonia S. Anand, Mark R. Nehler, Manesh R. Patel, E. Sebastian Debus, Michael Szarek, Warren H. Capell, Eva Muehlhofer, Scott D. Berkowitz, Lloyd Haskell, Rupert Bauersachs, Marc P. Bonaca, Judith Hsia	2022	7
10	Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease Cardiovascular Research ·Yan Liang, Jun Zhu, Lisheng Liu, Sonia S. Anand, Stuart J. Connolly, Jackie Bosch, Tomasz J. Guzik, Martin O’Donnell, Gilles R. Dagenais, Keith A.A. Fox, Olga Shestakovska, Scott D. Berkowitz, Eva Muehlhofer, M. Ya. Yastrubskyi, Salim Yusuf, John W. Eikelboom, (unknown)	2020	19
11	Navigate ESUS: Multicenter, randomized double-blind, phase III study of prevention of recurrent stroke and systemic embolism in patients with recent embolic stroke of undetermined source International Journal of Stroke ·Roland Veltkamp, Antoni Dávalos, Danilo Toni, 石田恭子, Raf Brouns, K.W. Muir, Hardi Mundl, Scott D. Berkowitz, Ashkan Shoamanesh, 强国令	2015	2
12	Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) The Lancet ·Jeffrey B. Washam, Susanna R. Stevens, Yuliya Lokhnygina, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Kenneth W. Mahaffey, Graeme J. Hankey, Scott D. Berkowitz, Christopher C. Nessel, Keith A.A. Fox, Robert M. Califf, Jonathan P. Piccini, Manesh R. Patel	2015	95
13	OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL Journal of the American College of Cardiology ·Ismael Manassés da Silva Santos, Derek D. Cyr, Yuliya Lokhnygina, Richard C. Becker, Scott D. Berkowitz, G Breithardt, Robert M. Califf, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Christopher C. Nessel, Jonathan P. Piccini, Daniel E. Singer, Manesh R. Patel	2014	2
14	Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation Circulation Heart Failure ·Sean van Diepen, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D. Berkowitz, Robert M. Califf, Keith A.A. Fox, Kenneth W. Mahaffey	2013	83
15	Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin) Acta Anaesthesiologica Scandinavica ·Nadia Rosencher, Juan V. Llau, Wolfgang Mueck, Ian R. Newby, Scott D. Berkowitz, Martin Homering	2013	23
16	Abstract 15544: Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Subgroup Analysis of the ROCKET AF Trial Circulation ·Jonathan L. Halperin, Zachary T. Bloomgarden, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D. Berkowitz, Robert M. Califf, Keith A.A. Fox, Kenneth W. Mahaffey	2012	4
17	POOLED ANALYSIS OF FOUR STUDIES OF RIVAROXABAN: EFFECT ON SYMPTOMATIC EVENTS AND BLEEDING AND THE INFLUENCE OF CLINICALLY RELEVANT PATIENT SUBGROUPS CHEST Journal ·Alexander G.G. Turpie, Michael R. Lassen, Ajay K. Kakkar, Bengt I. Eriksson, Scott D. Berkowitz, Frank Misselwitz, Tiemo J. Bandel, Martin Homering, Torsten Westermeier, Michael Gent	2009	3
18	Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty Annals of Internal Medicine ·Charles W. Francis, Bruce L. Davidson, Scott D. Berkowitz, Paul A. Lotke, Jeffrey S. Ginsberg, Jay R. Lieberman, Kyle Stroh, James P. Whipple, Gary Peters, Clifford W. Colwell	2002	47
19	Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium Journal of Cardiothoracic and Vascular Anesthesia ·Hilary P. Grocott, C. A. Robinson, Scott D. Berkowitz, Iris Judith Horna León, Kevin Landolfo	1997	17
20	Myocardial insufficiency during operation; its recognition and treatment with acetyl strophanthidin. PubMed ·Madhusudan Vudathala, Scott D. Berkowitz	1955	2

About Scott D. Berkowitz

Scott D. Berkowitz is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Surgery and Pulmonary and Respiratory Medicine, having authored 195 papers that have together received 17.0k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (100 papers), Venous Thromboembolism Diagnosis and Management (99 papers), Antiplatelet Therapy and Cardiovascular Diseases (55 papers), Acute Myocardial Infarction Research (38 papers), Cardiac Arrhythmias and Treatments (28 papers), Peripheral Artery Disease Management (25 papers), Acute Ischemic Stroke Management (20 papers) and Platelet Disorders and Treatments (18 papers). The work is most often cited by research in Internal Medicine (8.8k citations), Cardiology and Cardiovascular Medicine (13.6k citations), Hematology (2.0k citations), Surgery (3.3k citations) and Epidemiology (1.9k citations). Scott D. Berkowitz has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Keith A.A. Fox, Manesh R. Patel, Kenneth W. Mahaffey, Daniel E. Singer, Christopher C. Nessel, Graeme J. Hankey, Jonathan P. Piccini, Günter Breithardt, Jonathan L. Halperin and Richard C. Becker. Their work appears in journals such as Journal of the American College of Cardiology, American Heart Journal, Circulation, Blood and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact